| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 81,466 | 70,753 | 70,040 | 79,244 | | Cost of Revenue | 65,468 | 51,878 | 55,766 | 61,295 | | | Gross Profit | 15,998 | 18,875 | 14,274 | 17,949 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,699 | 8,740 | 7,199 | 9,099 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,299 | 10,135 | 7,075 | 8,850 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (472) | 95 | 103 | 155 | | Earnings Before Interest And Taxes | 8,377 | 10,230 | 7,178 | 9,005 | | Interest Expense | 88 | 231 | 206 | 391 | | Income Before Tax | 8,289 | 9,999 | 6,972 | 8,614 | | Income Tax Expense | 2,892 | 3,714 | 2,630 | 3,150 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,397 | 6,285 | 4,342 | 5,464 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,397 | 6,285 | 4,342 | 5,464 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,397 | $6,285 | $4,342 | $5,464 |
|
0.02% Nasdaq 
0.33%
Income Statement
